Onconome receives $231,000 cash grant under QTDP program

Onconome, Inc. announced today that it was awarded a cash grant totaling approximately $231,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was enacted as part of the Patient Protection and Affordable Care Act of 2010.

Onconome submitted a single grant application for its serum based Colon Cancer Rule Out Test currently in development. "We are very pleased to be among the companies chosen to receive a grant under this program," said Randy Brock, Onconome's President.  "We believe our non-invasive Colon Cancer Rule Out Test now in development will give healthcare providers a valuable new tool to use in their overall approach to diagnosing this disease. Proceeds from the grant will be used to support ongoing development of this test."